Valion Bio and 3i, LP amend Series B side letter for closing option
Valion Bio and 3i, LP amended their prior Side Letter, supporting the Purchaser's right to close on up to $1,600,000 of Series B Preferred Shares and warrants.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed